chartexchange

SABS
SAB Biotherapeutics, Inc. Common Stock
stockNASDAQ

Market OpenNov 19, 2026 3:59:18 PM EST
2.90USD-9.375%(-0.30)1,680,483
2.9000Bid2.9200Ask0.0200Spread

SABS Financials

In Q3 FY 2026 (ended ), SAB Biotherapeutics, Inc. Common Stock (SABS) reported revenue of $0, net income of −$22.3M, operating cash flow of −$13.02M, and assets of $235.64M (filed ).

Loading financial statements…